Search En menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Summary sheet

Release date
5 June 2024
Status
Reference
Approved | 28/08/2024
20240287
Project name
Promoter - financial intermediary
GLOBAL HEALTH MARKET-SHAPING FACILITY
ACCEPTABLE CORPORATE(S)
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 52 million
EUR 300 million
Location
Sector(s)
  • Health - Human health and social work activities
Description
Objectives

The project supports the manufacturers of medicines, vaccines, diagnostics and medical devices to scale and optimise their supply mechanisms to be able to meet global demand. The project is funded by a master guarantee facility in favour of the Bill & Melinda Gates Foundation that shapes healthy markets for critical products to ensure accessibility and affordability to low- and middle-income populations.

The operation is fully aligned with the priorities of Global Gateway as it supports the affordable access to medical products to tackle endemic, infectious and non-communicable diseases. It will also support the TEI on Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+). Ensuring affordability and accessibility to quality medical products in LMICs will contribute to the eradication of poverty, which is a pillar of NDICI across all regions.

Environmental aspects
Procurement

The Bank will require the intermediary institution to take all the requisite measures to ensure that the final beneficiaries undertake to implement and operate the sub-projects under the New Portfolio in compliance with the applicable national legislation and the relevant EIB Environmental and Social Standards.

The Bank will require that implementation of the project will be done in accordance with the Bank's Guide to Procurement.

Milestone
Under appraisal
Approved
28 August 2024
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - GLOBAL HEALTH MARKET-SHAPING FACILITY
Publication Date
30 Aug 2024
Document language
Main Topic
Lending
Document Number
213746102
Document Focus
Environmental Information
Project Number
20240287
Sector(s)
Countries
Publicly available
Download now
Other links

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications